NA Semax Amidate

NA Semax Amidate is a structure-optimized analog of semax. It is an N-terminally acetylated and C-terminally amidated derivative of the Semax peptide, which preserves the core sequence.

 

გააზიარე შენი სიყვარული

NA Semax Amidate is a structure-optimized analog of semax. It is an N-terminally acetylated and C-terminally amidated derivative of the Semax peptide, which preserves the core sequence.

This artificial modification markedly improves the resistance of the peptide chain against exo- and endopeptidases (for example leucine aminopeptidase), extending its half-life by about 30 minutes compared with the original Semax, with an overall duration of action of 6-12 საათები.

It also enhances room temperature storage stability and nasal mucosal absorption efficiency, thereby ensuring more reliable penetration of the blood-brain barrier (BBB) and the sustained maintenance of an effective concentration gradient in brain tissue.

Its core mechanism lies in multi-pathway modulation of ცენტრალური ნერვული სისტემა function.

First and foremost, NA Semax Amidate acts as a powerful upregulator of brain-derived neurotrophic factor (BDNF), which in turn enhances neuronal survival, axonal growth, სინაფსური პლასტიურობა და long-term potentiation (LTP) — the molecular basis for learning and memory.

მეტიც,NA Semax Amidate potentiates dopaminergic, serotonergic, and noradrenergic neurotransmission, thereby optimizing prefrontal cortex executive functions, including attention selectivity and working memory capacity.

NA Semax Amidate also exhibits significant neuroprotective effects by suppressing inflammatory cytokine release, reducing oxidative stress damage, and stabilizing mitochondrial membrane potential.

It is effective against various pathological insults such as cerebral ischemia, hypoxia, ტრავმა, და neurodegeneration.

It is approved in Russia as adjunctive therapy for acute stroke, traumatic brain injury, and early-stage Parkinson’s disease.

მოკლედ, NA Semax Amidate utilizes chemical modifications to overcome the limitations of the natural peptide, thereby surpassing conventional Semax in cognitive enhancement, neuroprotection, mood regulation, and injury repair.

This holds significant clinical importance for the treatment of ნეიროდეგენერაციული დაავადებები and the promotion of central nervous system functional recovery.

თანმიმდევრობა

AC-met-glu-his-phe-pro-gly-pro-nh2

CAS ნომერი

/

მოლეკულური ფორმულა

C39H54N10O10S

მოლეკულური წონა

854.98

Research Of NA Semax Amidate

NA Semax Amidate demonstrates efficacy comparable to classical ანქსიოლიზური drugs in several preclinical models.

1.Cognitive Enhancement and Neural Plasticity

NA Semax Amidate activates the transcription factor CREB, upregulating BDNF gene expression and increasing neuronal BDNF levels by over 40%.

This in turn promotes dendritic spine formation, axonal guidance, and aggregation of postsynaptic density protein 95 (PSD-95), thereby enhancing learning capacity.

Biological simulation experiments demonstrate a 35-50% improvement in memory retention rates in contextual fear conditioning ტესტები.

Brain slice electrophysiological recordings confirm increased LTP amplitude and duration, indicating that NA Semax Amidate reshapes სინაფსური პლასტიურობა thresholds through profound activation of the ნეიროტროფიული ფაქტორი network.

2.Neuroprotection and Repair

NA Semax Amidate activates the adenylate cyclase (AC)-cAMP-PKA pathway to stabilize mitochondrial membrane potential, inhibits cytochrome C release, and suppresses caspase-3 cascade activation, thereby blocking the execution phase of აპოპტოზი.

Concurrently, it upregulates superoxide dismutase expression and inhibits excessive inflammatory ციტოკინი წარმოება.

In a rat middle cerebral artery occlusion model, it reduced cerebral infarction volume by over 50%.

In an MPTP model of Parkinson’s disease, it increased dopaminergic neuron survival by 35%, demonstrating potent neuroprotection.

3.Anxiolytic and Analgesic Effects

NA Semax Amidate increases affinity for endogenous enkephalins და β-endorphin while inhibiting G protein-coupled receptor kinase (GRK)-mediated receptor internalization and desensitization, thereby prolonging analgesic signaling.

It also reduces FTO-mediated inflammatory pain hypersensitivity.

In mouse models, pain thresholds were elevated by 30-40% and remained elevated for 4 რომ 6 საათები.

In chronic constriction injury (CCI) models, mechanical allodynia was alleviated by 50%, further confirming NA Semax Amidate’s clear anti-stress and mood-stabilizing properties.

NA Semax Amidate demonstrates efficacy comparable to classical anxiolytic drugs in several preclinical models.

4.Cognitive Enhancement and Neural Plasticity

NA Semax Amidate activates the transcription factor CREB, upregulating BDNF gene expression and increasing neuronal BDNF levels by over 40%.

This in turn promotes dendritic spine formation, axonal guidance, and aggregation of postsynaptic density protein 95 (PSD-95), thereby enhancing learning capacity.

Biological simulation experiments demonstrate a 35-50% improvement in memory retention rates in contextual fear conditioning tests.

Brain slice electrophysiological recordings confirm increased LTP amplitude and duration, indicating that NA Semax Amidate reshapes synaptic plasticity thresholds through profound activation of the neurotrophic factor network.

5.Neuroprotection and Repair

NA Semax Amidate activates the adenylate cyclase (AC)-cAMP-PKA pathway to stabilize mitochondrial membrane potential, inhibits cytochrome C release, and suppresses caspase-3 cascade activation, thereby blocking the execution phase of apoptosis.

Concurrently, it upregulates superoxide dismutase expression and inhibits excessive inflammatory cytokine production.

In a rat middle cerebral artery occlusion model, it reduced cerebral infarction volume by over 50%.

In an MPTP model of Parkinson’s disease, it increased dopaminergic neuron survival by 35%, demonstrating potent neuroprotection.

6.Anxiolytic and Analgesic Effects

NA Semax Amidate increases affinity for endogenous enkephalins and β-endorphin while inhibiting G protein-coupled receptor kinase (GRK)-mediated receptor internalization and desensitization, thereby prolonging analgesic signaling.

It also reduces FTO-mediated inflammatory pain hypersensitivity.

In mouse models, pain thresholds were elevated by 30-40% and remained elevated for 4 რომ 6 საათები.

In chronic constriction injury (CCI) models, mechanical allodynia was alleviated by 50%, further confirming NA Semax Amidate’s clear anti-stress and mood-stabilizing properties.

COA

HPLC

MS

(1) Dmitrieva, ვ. გ.; Povarova, ო. ვ.; Skvortsova, ვ. მე.; Limborska, ს. ა.; მიასოედოვი, ნ. ფ.; Dergunova, ლ. ვ. Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptor Genes after Cerebral Ischemia. Cellular and Molecular Neurobiology 2009, 30 (1), 71-79. DOI: 10.1007/s10571-009-9432-0.

(2) Eremin, კ. ო.; კუდრინი, ვ. ს.; Saransaari, პ.; Oja, ს. ს.; გრივენნიკოვი, მე. ა.; მიასოედოვი, ნ. ფ.; Rayevsky, კ. ს. Semax, An ACTH(4-10) Analogue with Nootropic Properties, Activates Dopaminergic and Serotoninergic Brain Systems in Rodents. Neurochemical Research 2005, 30 (12), 1493-1500. DOI: 10.1007/s11064-005-8826-8.

(3) Glazova, ნ. ი.; Manchenko, დ. მ.; Volodina, მ. ა.; Merchieva, ს. ა.; ანდრეევა, ლ. ა.; კუდრინი, ვ. ს.; მიასოედოვი, ნ. ფ.; Levitskaya, ნ. გ. Semax, synthetic ACTH(4–10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Neuropeptides 2021, 86. DOI: 10.1016/j.npep.2020.102114.

(4) ღირებულება, ნ. ვ.; სოკოლოვი, ო.; გაბაევა, მ. ვ.; გრივენნიკოვი, მე. ა.; ანდრეევა, ლ. ა.; მიასოედოვი, ნ. ფ.; ზოზულია, ა. ა. [სემაქსი და სელანკი აინჰიბირებენ ენკეფალინის დეგრადირებად ფერმენტებს ადამიანის შრატში]]. ბიოორგ ხიმ 2001, 27 (3), 180-183. DOI: 10.1023/ა:1011373002885 NLM Medline-დან.

(5) მედვედევა, ე. ვ.; Dmitrieva, ვ. გ.; Limborska, ს. ა.; მიასოედოვი, ნ. ფ.; Dergunova, ლ. ვ. Semax, an analog of ACTH(4−7), regulates expression of immune response genes during ischemic brain injury in rats. Molecular Genetics and Genomics 2017, 292 (3), 635-653. DOI: 10.1007/s00438-017-1297-1.

(6) Pae, C.-U. Therapeutic Possibility of “Semax” for Depression. CNS Spectrums 2014, 13 (1), 20-21. DOI: 10.1017/s1092852900016102.

(7) Vlasova, მე. მ.; Buravtcov, დ. ე.; Saletsky, ა. მ. Luminescence analysis of blood components in studies of the neuroprotective properties of the drug “Semax” in cerebral ischemia. Journal of Applied Spectroscopy 2009, 76 (1), 121-126. DOI: 10.1007/s10812-009-9141-y.

თანმიმდევრობა:

AC-met-glu-his-phe-pro-gly-pro-nh2

CAS:

/

მ.ვ:

854.98 გ/მოლ

მთავარი ძიება Whatsapp სერვისები პროდუქტი